Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10233209
Inhibitors of the farnesoid x receptor and uses in medicine
granted -
US 10233152
LSD1 inhibitors
granted -
US 10231974
Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors
granted -
US 10233170
2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use
granted -
US 10226452
Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments
granted -
US 10226468
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10227323
Glucosylceramide synthase inhibitors for the treatment of diseases
granted -
US 10227312
Glucosylceramide synthase inhibitors for the treatment of diseases
granted -
US 10221161
Inhibitors of plasma kallikrein
granted -
US 10221174
N-(phenylsulfonyl)benzamides and related compounds as BCL-2 inhibitors
granted -
US 10214509
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
granted -
US 10214522
Anti-alphavbeta1 integrin inhibitors and methods of use
granted -
US 2019055264
Macrocyclic MCL-1 inhibitors and methods of use
granted -
US 10208040
Fused imidazo-piperidine JAK inhibitors
granted -
US 10206924
Small molecule inhibitors of EGFR and PI3K
granted -
US 10202366
Methods of promoting wound healing using CRM1 inhibitors
granted -
US 10202340
Glucosylceramide synthase inhibitors and therapeutic methods using the same
granted -
US 10196424
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 10195214
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 10196393
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10196378
Inhibitors of BCR-ABL mutants and use thereof
granted -
US 10189823
Neprilysin inhibitors
granted -
US 10189784
N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase
granted -
US 10183933
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
granted